Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort

Colaboración

Año: 2018

Sarink, D; Schock, H; Johnson, T; Chang-Claude, J; Overvad, K; Olsen, A; Tjonneland, A; Arveux, P; Fournier, A; Kvaskoff, M; Boeing, H; Karakatsani, A; Trichopoulou, A; Vecchia, C; Masala, G; Agnoli, C; Panico, S; Tumino, R; Sacerdote, C; Gils, CH; Peeters, PHM; Weiderpass, E; Agudo, A; Rodriguez-Barranco, M; Huerta, J; Ardanaz, E; Gil, L; Kaw, KT; Schmidt, JA; Dossus, L; His, M; Aune, D; Riboli, E; Kaaks, R; Fortner, RT

Título: BMC CANCER

• Q2